CytaCoat AB is a private Swedish company located in the Karolinska Institutet Science Park AB in Solna (Stockholm area). CytaCoat has developed a unique, stable and universal antimicrobial coating for prevention of Healthcare-Associated Infections (HAIs) related with the use of invasive and non-invasive medical devices. This strong chemical bond in the antibacterial coating provides stability and prevents the release of components with potential toxic or accumulation effects in the patient. This avoids the use of antibiotics and the ability of bacteria to develop resistance. The strategy is to sell the technology and defined protocol to medical device manufacturing companies via out-licensing deals.